LSIPR 50 2018: Issi Rozen—It’s not like selling cars
Balancing a company’s duty to shareholders with the public responsibility to provide lifesaving treatments is a constant challenge, as Issi Rozen, chief business officer at the Broad Institute of MIT and Harvard, tells LSIPR.
Latest news
US court rejects Jazz attempt to revive Xyrem patents
17-07-2018
The US Court of Appeals for the Federal Circuit has rejected Jazz Pharmaceuticals’ attempt to revive patents covering its narcolepsy drug Xyrem.
50 Key Influencers In The Life Sciences
Regions
Sectors
